Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo

NCT01760304 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Sponsor decided to stop the study due to expiration of blinded placebo .

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Budesonide / Formoterol
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]